SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001193125-14-219419
Filing Date
2014-05-30
Accepted
2014-05-30 14:08:55
Documents
13
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 40-F d735487d40f.htm 40-F 34286
2 EX-99.1 d735487dex991.htm EX-99.1 507172
3 EX-99.2 d735487dex992.htm EX-99.2 1007851
4 EX-99.3 d735487dex993.htm EX-99.3 403873
5 EX-99.4 d735487dex994.htm EX-99.4 5403
6 EX-99.5 d735487dex995.htm EX-99.5 11170
7 EX-99.6 d735487dex996.htm EX-99.6 4195
8 GRAPHIC g735487001.jpg GRAPHIC 2358
9 GRAPHIC g735487002.jpg GRAPHIC 2536
10 GRAPHIC g735487003.jpg GRAPHIC 9048
11 GRAPHIC g735487004.jpg GRAPHIC 15479
12 GRAPHIC g735487005.jpg GRAPHIC 15526
13 GRAPHIC g735487img01.jpg GRAPHIC 3350
  Complete submission text file 0001193125-14-219419.txt   2042417
Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Neptune Technologies & Bioressources Inc. (Filer) CIK: 0001401395 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 40-F | Act: 34 | File No.: 001-33526 | Film No.: 14879224
SIC: 2834 Pharmaceutical Preparations